PHARMACOLOGICAL CHARACTERIZATION OF THE NUCLEOTIDE RECEPTORS THAT MOBILIZE CA2+ IONS IN HUMAN PARATHYROID CELLS

We have used the fluorescent probe fura-2 to perform m agonist studies of the receptor(s) that mobilizes Ca2+ ions in response to extracellu lar ATP in human parathyroid cells. Extracellular ATP induced Ca2+ res ponses in both normal and adenomatous parathyroid cells. Activation re sulted in an initial small transient response during which Ca2+ ions w ere released from intracellular stores, followed by a prominent platea u response during which Ca2+ ions entered the cells from the extracell ular fluid. The responses exhibited moderate desensitization upon repe ated stimulation with ATP, and the ratio of the plateau to the peak re sponse remained constant for any given group of activated cells. The b aseline intracellular calcium concentration was 100 +/- 4.3 nM (mean /- S.E.M., n=3). Following maximal activation by extracellular ATP it rose to a peak of 684 +/- 457 nM (n=3) and a plateau level of415 +/- 9 .9 nM (n=3). We examined the effects of a variety of nucleotide specie s. The order of potency was: adenosine, AMP<alpha,beta-methylene ATP<A DP<ATP approximate to UTP. In the concentration range 1-1000 mu M, UTP (the concentration of agonist inducing a half-maximal response, EC(50 )=2.4 mu M) was slightly more potent than ATP (EC(50)=3.6 mu M), and t he two nucleotides evoked similar maximal responses. In the concentrat ion range 0.01-1.0 mu M, however, there was a clear difference in the behaviour of the two nucleotides. In particular, ATP, but not UTP, evo ked responses that suggested the presence of a second receptor of high er potency but markedly lower efficacy. Responses to 2-methylthioATP ( 2-MeSATP) in the concentration range 0.01-100 mu M defined a dose-resp onse curve that matched the lower concentration component of the ATP d ose-response curve. Together, these data suggest that two receptor spe cies are involved in the Ca2+ responses. One is a nucleotide/P-2U rece ptor that responds to ATP and UTP, which are approximately equipotent agonists; 2-MeSATP is only a weak agonist with respect to this recepto r. The other belongs to the P-2Y receptor subclass. It responds to 2-M eSATP, a selective agonist at P-2Y receptors, and to ATP, but not to t he pyrimidine nucleotide UTP.